Literature DB >> 29139482

Opioid misuse in gastroenterology and non-opioid management of abdominal pain.

Eva Szigethy1, Mitchell Knisely2, Douglas Drossman3,4.   

Abstract

Opioids were one of the earliest classes of medications used for pain across a variety of conditions, but morbidity and mortality have been increasingly associated with their chronic use. Despite these negative consequences, chronic opioid use is increasing worldwide, with the USA and Canada having the highest rates. Chronic opioid use for noncancer pain can have particularly negative effects in the gastrointestinal and central nervous systems, including opioid-induced constipation, narcotic bowel syndrome, worsening psychopathology and addiction. This Review summarizes the evidence of opioid misuse in gastroenterology, including the lack of evidence of a benefit from these drugs, as well as the risk of harm and negative consequences of opioid use relative to the brain-gut axis. Guidelines for opioid management and alternative pharmacological and nonpharmacological strategies for pain management in patients with gastrointestinal disorders are also discussed. As chronic pain is complex and involves emotional and social factors, a multimodal approach targeting both pain intensity and quality of life is best.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29139482      PMCID: PMC6421506          DOI: 10.1038/nrgastro.2017.141

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  192 in total

Review 1.  Hypnosis and Guided Imagery Treatment for Gastrointestinal Disorders: Experience With Scripted Protocols Developed at the University of North Carolina.

Authors:  Olafur S Palsson; Miranda van Tilburg
Journal:  Am J Clin Hypn       Date:  2015-07

Review 2.  Opioidergic effects on enteric and sensory nerves in the lower GI tract: basic mechanisms and clinical implications.

Authors:  Patrick A Hughes; Samuel P Costello; Robert V Bryant; Jane M Andrews
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-07-28       Impact factor: 4.052

Review 3.  Definitions and outcome measures of clinical trials regarding opioid-induced constipation: a systematic review.

Authors:  Jan Gaertner; Waldemar Siemens; Michael Camilleri; Andrew Davies; Douglas A Drossman; Lynn R Webster; Gerhild Becker
Journal:  J Clin Gastroenterol       Date:  2015-01       Impact factor: 3.062

4.  Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions.

Authors:  S S Martins; M C Fenton; K M Keyes; C Blanco; H Zhu; C L Storr
Journal:  Psychol Med       Date:  2011-10-17       Impact factor: 7.723

5.  Differential development of acute tolerance to analgesia, respiratory depression, gastrointestinal transit and hormone release in a morphine infusion model.

Authors:  G S Ling; D Paul; R Simantov; G W Pasternak
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

6.  An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder.

Authors:  Roberto Lewis-Fernández; Peter Lam; Susan Lucak; Hanga Galfalvy; Elizabeth Jackson; Jane Fried; Melissa Rosario; Ana Alicia de la Cruz; Arturo Sánchez-Lacay; Samantha Díaz; Franklin Schneier
Journal:  J Clin Psychopharmacol       Date:  2016-12       Impact factor: 3.153

Review 7.  Non-pharmacological management of abdominal pain-related functional gastrointestinal disorders in children.

Authors:  Siba Prosad Paul; Dharamveer Basude
Journal:  World J Pediatr       Date:  2016-06-30       Impact factor: 2.764

8.  Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians.

Authors:  Yuhua Bao; Yijun Pan; Aryn Taylor; Sharmini Radakrishnan; Feijun Luo; Harold Alan Pincus; Bruce R Schackman
Journal:  Health Aff (Millwood)       Date:  2016-06-01       Impact factor: 6.301

9.  "Pressured to prescribe" The impact of economic and regulatory factors on South-Eastern ED physicians when managing the drug seeking patient.

Authors:  Sharon Kelly; Giffe T Johnson; Raymond D Harbison
Journal:  J Emerg Trauma Shock       Date:  2016 Apr-Jun

10.  Patients With Short Bowel on Narcotics During 2 Randomized Trials Have Abdominal Complaints Independent of Teduglutide.

Authors:  Ken Fujioka; Khursheed Jeejeebhoy; Ulrich-Frank Pape; Benjamin Li; Nader N Youssef; Stéphane M Schneider
Journal:  JPEN J Parenter Enteral Nutr       Date:  2016-08-09       Impact factor: 4.016

View more
  23 in total

Review 1.  Advances in Management of Esophageal Motility Disorders.

Authors:  Peter J Kahrilas; Albert J Bredenoord; Dustin A Carlson; John E Pandolfino
Journal:  Clin Gastroenterol Hepatol       Date:  2018-04-24       Impact factor: 11.382

2.  Pain Management in Patients With Inflammatory Bowel Disease.

Authors:  Eva Szigethy
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-01

3.  High-Dose Opioid Use Among Veterans with Unexplained Gastrointestinal Symptoms Versus Structural Gastrointestinal Diagnoses.

Authors:  Salva N Balbale; Lishan Cao; Itishree Trivedi; Jonah J Stulberg; Katie J Suda; Walid F Gellad; Charlesnika T Evans; Bruce L Lambert; Neil Jordan; Laurie A Keefer
Journal:  Dig Dis Sci       Date:  2021-01-01       Impact factor: 3.199

4.  Diabetic Gastroparesis.

Authors:  Adil E Bharucha; Yogish C Kudva; David O Prichard
Journal:  Endocr Rev       Date:  2019-10-01       Impact factor: 19.871

Review 5.  Dual Enkephalinase Inhibitors and Their Role in Chronic Pain Management.

Authors:  Warren A Southerland; Justin Gillis; Sumanth Kuppalli; Alex Fonseca; Andrew Mendelson; Storm V Horine; Nitin Bansal; Amitabh Gulati
Journal:  Curr Pain Headache Rep       Date:  2021-03-24

6.  The Prevalence, Comorbidity, Management and Costs of Irritable Bowel Syndrome.

Authors:  Winfried Häuser; Ursula Marschall; Peter Layer; Thomas Grobe
Journal:  Dtsch Arztebl Int       Date:  2019-07-08       Impact factor: 5.594

Review 7.  [Pain inhibition by opioids-new concepts].

Authors:  C Stein
Journal:  Anaesthesist       Date:  2019-02       Impact factor: 1.041

Review 8.  Managing Pain and Psychosocial Care in IBD: a Primer for the Practicing Gastroenterologist.

Authors:  Emily Weaver; Eva Szigethy
Journal:  Curr Gastroenterol Rep       Date:  2020-03-17

Review 9.  A Scoping Review of Nursing's Contribution to the Management of Patients with Pain and Opioid Misuse.

Authors:  Janet H Van Cleave; Staja Q Booker; Keesha Powell-Roach; Eva Liang; Jennifer Kawi
Journal:  Pain Manag Nurs       Date:  2021-01-05       Impact factor: 1.929

Review 10.  Gastrointestinal pain.

Authors:  Asbjørn M Drewes; Anne E Olesen; Adam D Farmer; Eva Szigethy; Vinciane Rebours; Søren S Olesen
Journal:  Nat Rev Dis Primers       Date:  2020-01-06       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.